7:24 AM
 | 
Jun 20, 2018
 |  BC Extra  |  Financial News

Aminex raises $10M, starts Phase I cancer trial

Aminex Therapeutics Inc. (Seattle, Wash.) raised $10 million in an untranched series B round. The company declined to name its investors.

The company...

Read the full 91 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >